Researcher Profile

Jeffrey Siegel

🏛 Genentech, South San Francisco, California

Publications

3,124

Citations

Co-Authors

Active Years

Publications

Open Access Journal Article Kidney International Apr 01, 2025

Six-month safety and efficacy outcomes from the randomized-controlled arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial

Mahmood K. Razavi · Saravanan Balamuthusamy · Angelo N. Makris · Jeffrey G. Hoggard +40 more

10.1016/j.kint.2025.01.006 6 citations

Open Access Journal Article American Review of Respiratory Disease Mar 01, 2022

Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial

Dinesh Khanna · Celia J. F. Lin · Daniel E. Furst · Bridget Wagner +6 more

10.1164/rccm.202103-0714oc 109 citations

Journal Article The Lancet Respiratory Medicine Oct 01, 2020

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna · Celia J F Lin · Daniel E Furst · Jonathan Goldin +89 more

10.1016/s2213-2600(20)30318-0 583 citations

Open Access Journal Article Nature Nov 01, 2017

A communal catalogue reveals Earth’s multiscale microbial diversity

Luke R. Thompson · Jon G. Sanders · Daniel McDonald · Amnon Amir +298 more

10.1038/nature24621 2,426 citations

Publication Timeline

2025

2022

2020

2017

Frequent Co-Authors

Christopher P. Denton

2×

2×

2×

2×

2×

1×

1×

1×

1×

1×